A new study offering greater understanding of the mechanisms involved in the interaction between obesity and breast cancer could help to personalise treatment for some patients. Researchers from the ...

During a live event, Kit Yu Lu, MD, discussed data on antibody-drug conjugates in HR+, HER2- breast cancer including the ...

Breast cancer remains one of the predominant causes of cancer-related morbidity worldwide. In recent years, research has increasingly focused on the role of immune markers in predicting patient ...

GRAND RAPIDS, Mich. — BAMF Health, a cancer treatment center in Grand Rapids, has launched a study to better understand a certain type of breast cancer. The non-invasive study seeks to find whether or ...

The HEROES trial explores de-escalation of anti-HER2 therapy in metastatic HER2+ breast cancer using the Signatera test to guide treatment decisions. The trial aims to enroll 170 patients, focusing on ...

"Therapy for small, node-negative, HER2-positive breast cancer can be challenging due to the risk of overtreatment. Our study can help assess outcomes of patients according to specific tumor sizes and ...

Envision this possible future clinical scenario: a breast cancer patient and her physicians are deciding on the best possible treatment. Their decision is informed by a comprehensive molecular profile ...

Enhertu showed significant improvement in pathologic complete response rates in high-risk HER2-positive early-stage breast cancer compared with standard care. The DESTINY-Breast11 trial indicated ...

Scientists have long suspected that stress hormones help fuel the spread of cancer. Now, new research has uncovered how a ...